Rijuven has announced the launch of CardioSleeve for Pediatrics, the first FDA-cleared device that adds ECG capabilities to transform any existing stethoscope into a smart, mobile-connected device.
According to the company, the device can quickly and accurately visualize heart sound, analyze for arrhythmia or murmur, and identify heart failure.
‘Clinicians simply attach the device to a stethoscope. The device swiftly and accurately obtains the digital acoustic and electric footprints of the heart and transmits them to a mobile for real-time analysis’
Clinicians simply attach the CardioSleeve to an existing stethoscope. The device quickly and accurately acquires the digital acoustic and electric footprints of the heart and transmits them to a mobile device for real-time analysis. This allows for the creation of the Systolic Performance Index, a measure of Ejection Fraction, critical to identifying heart failure.
"Stethoscopes have been around for almost 200 years, it's time to bring them into the 21st century. With CardioSleeve and the i2Dtx platform, Pediatricians now have the power of ECG right on the stethoscopes they already know and love. CardioSleeve makes existing stethoscopes smarter so they can do things an ordinary stethoscope can't: visualize a heart murmur, quickly analyze heart rhythm, and identify heart failure, all while reducing costs and enhancing patient care," said Rijuven President and Co-founder Raj Kapoor, MD, FCCP.
CardioSleeve for Pediatrics and its companion mobile app features:
- Digital Auscultation with ECG
- Murmur Detection and Analysis at beats up to 180 BPM
- High Fidelity 3-Lead ECG
- Systolic Performance Index
- Digital Caliper
- FDA clearance for both device and analysis
- HIPAA secure data transfer and cloud-based EMR
- Wireless Bluetooth connectivity
- IOS, Android, and PC compatibility
- Easy attachment to any traditional stethoscope
- Dry-contact and biocompatible surfaces